IndraLab

Statements

Val-Ala inhibits ITCH. 2 / 2

| 2

reach

"Both VA and cetirizine significantly reduced type I hypersensitivity itch in patients with AD, compared with both placebo and NI."

22313287

➶

reach

"Both VA and cetirizine significantly reduced type-I-hypersensitivity itch in AD patients, compared to both placebo and NI."

22313287

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Val-Ala inhibits ITCH. 2 / 2

INDRA sources:

Databases

Reading